Studies have shown that theacrine can inhibit liver steatosis and liver inflammation in NAFLD by promoting the metabolism of acylcarnitine through Sirtuin3/LCAD signalling pathways [27]. The gene discussed is ACADL; the disease is metabolic dysfunction-associated steatotic liver disease.